George M. Jenkins, Director at PALVELLA THERAPEUTICS, INC. (PVLA), sold 27,500 shares at $150.62 ($4.2M) on 2026-09-11, disclosed to the SEC on 2026-09-15.
Scheduled sale ($4.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.62 | 6,520 | $982K | 23.6% |
| 2 | $151.72 | 4,577 | $694K | 16.7% |
| 3 | $153.06 | 1,274 | $195K | 4.7% |
| 4 | $151.46 | 5,632 | $853K | 20.5% |
| 5 | $152.12 | 6,160 | $937K | 22.5% |
| 6 | $153.10 | 1,560 |
| $239K |
| 5.7% |
| 7 | $149.38 | 954 | $143K | 3.4% |
| 8 | $150.40 | 263 | $40K | 0.9% |
| 9 | $151.33 | 560 | $85K | 2.0% |
| Total | $151.53 avg | 27,500 | $4.2M | 100% |
| Filing → |
| PVLA | BUY | 2025-04-10 | $151K | — | Filing → |
| PVLA | BUY | 2024-12-19 | $52K | — | Filing → |